Table of Content

1 RNA Drugs Market Overview
1.1 RNA Drugs Product Overview
1.2 RNA Drugs Market Segment by Type
1.2.1 siRNA
1.2.2 ASO
1.2.3 miRNA
1.2.4 Nucleic Acid Aptamers
1.3 Global RNA Drugs Market Size by Type
1.3.1 Global RNA Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global RNA Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global RNA Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America RNA Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe RNA Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific RNA Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America RNA Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa RNA Drugs Sales Breakdown by Type (2018-2024)
2 Global RNA Drugs Market Competition by Company
2.1 Global Top Players by RNA Drugs Sales (2018-2024)
2.2 Global Top Players by RNA Drugs Revenue (2018-2024)
2.3 Global Top Players by RNA Drugs Price (2018-2024)
2.4 Global Top Manufacturers RNA Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 RNA Drugs Market Competitive Situation and Trends
2.5.1 RNA Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by RNA Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into RNA Drugs Market
2.8 Key Manufacturers RNA Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 RNA Drugs Status and Outlook by Region
3.1 Global RNA Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global RNA Drugs Historic Market Size by Region
3.2.1 Global RNA Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global RNA Drugs Sales in Value by Region (2018-2024)
3.2.3 Global RNA Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global RNA Drugs Forecasted Market Size by Region
3.3.1 Global RNA Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global RNA Drugs Sales in Value by Region (2024-2034)
3.3.3 Global RNA Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global RNA Drugs by Application
4.1 RNA Drugs Market Segment by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Tuberculosis
4.1.4 Cardiovascular Diseases
4.1.5 Others
4.2 Global RNA Drugs Market Size by Application
4.2.1 Global RNA Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global RNA Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global RNA Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America RNA Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe RNA Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific RNA Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America RNA Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa RNA Drugs Sales Breakdown by Application (2018-2024)
5 North America RNA Drugs by Country
5.1 North America RNA Drugs Historic Market Size by Country
5.1.1 North America RNA Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America RNA Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America RNA Drugs Sales in Value by Country (2018-2024)
5.2 North America RNA Drugs Forecasted Market Size by Country
5.2.1 North America RNA Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America RNA Drugs Sales in Value by Country (2024-2034)
6 Europe RNA Drugs by Country
6.1 Europe RNA Drugs Historic Market Size by Country
6.1.1 Europe RNA Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe RNA Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe RNA Drugs Sales in Value by Country (2018-2024)
6.2 Europe RNA Drugs Forecasted Market Size by Country
6.2.1 Europe RNA Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe RNA Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific RNA Drugs by Region
7.1 Asia-Pacific RNA Drugs Historic Market Size by Region
7.1.1 Asia-Pacific RNA Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific RNA Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific RNA Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific RNA Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific RNA Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific RNA Drugs Sales in Value by Region (2024-2034)
8 Latin America RNA Drugs by Country
8.1 Latin America RNA Drugs Historic Market Size by Country
8.1.1 Latin America RNA Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America RNA Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America RNA Drugs Sales in Value by Country (2018-2024)
8.2 Latin America RNA Drugs Forecasted Market Size by Country
8.2.1 Latin America RNA Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America RNA Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa RNA Drugs by Country
9.1 Middle East and Africa RNA Drugs Historic Market Size by Country
9.1.1 Middle East and Africa RNA Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa RNA Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa RNA Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa RNA Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa RNA Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa RNA Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer RNA Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche RNA Drugs Products Offered
10.2.5 Roche Recent Development
10.3 Sanofi-Aventis
10.3.1 Sanofi-Aventis Company Information
10.3.2 Sanofi-Aventis Introduction and Business Overview
10.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi-Aventis RNA Drugs Products Offered
10.3.5 Sanofi-Aventis Recent Development
10.4 Abbott Laboratories
10.4.1 Abbott Laboratories Company Information
10.4.2 Abbott Laboratories Introduction and Business Overview
10.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Abbott Laboratories RNA Drugs Products Offered
10.4.5 Abbott Laboratories Recent Development
10.5 Arrowhead Pharmaceuticals
10.5.1 Arrowhead Pharmaceuticals Company Information
10.5.2 Arrowhead Pharmaceuticals Introduction and Business Overview
10.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Arrowhead Pharmaceuticals RNA Drugs Products Offered
10.5.5 Arrowhead Pharmaceuticals Recent Development
10.6 Benitec Biopharma
10.6.1 Benitec Biopharma Company Information
10.6.2 Benitec Biopharma Introduction and Business Overview
10.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Benitec Biopharma RNA Drugs Products Offered
10.6.5 Benitec Biopharma Recent Development
10.7 Calimmune Inc
10.7.1 Calimmune Inc Company Information
10.7.2 Calimmune Inc Introduction and Business Overview
10.7.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Calimmune Inc RNA Drugs Products Offered
10.7.5 Calimmune Inc Recent Development
10.8 Dicerna
10.8.1 Dicerna Company Information
10.8.2 Dicerna Introduction and Business Overview
10.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Dicerna RNA Drugs Products Offered
10.8.5 Dicerna Recent Development
10.9 Gradalis
10.9.1 Gradalis Company Information
10.9.2 Gradalis Introduction and Business Overview
10.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Gradalis RNA Drugs Products Offered
10.9.5 Gradalis Recent Development
10.10 Quark
10.10.1 Quark Company Information
10.10.2 Quark Introduction and Business Overview
10.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Quark RNA Drugs Products Offered
10.10.5 Quark Recent Development
10.11 RXi
10.11.1 RXi Company Information
10.11.2 RXi Introduction and Business Overview
10.11.3 RXi RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 RXi RNA Drugs Products Offered
10.11.5 RXi Recent Development
10.12 Senesco
10.12.1 Senesco Company Information
10.12.2 Senesco Introduction and Business Overview
10.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Senesco RNA Drugs Products Offered
10.12.5 Senesco Recent Development
10.13 Silence Therapeutics
10.13.1 Silence Therapeutics Company Information
10.13.2 Silence Therapeutics Introduction and Business Overview
10.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Silence Therapeutics RNA Drugs Products Offered
10.13.5 Silence Therapeutics Recent Development
10.14 Silenseed
10.14.1 Silenseed Company Information
10.14.2 Silenseed Introduction and Business Overview
10.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Silenseed RNA Drugs Products Offered
10.14.5 Silenseed Recent Development
10.15 Tekmira
10.15.1 Tekmira Company Information
10.15.2 Tekmira Introduction and Business Overview
10.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Tekmira RNA Drugs Products Offered
10.15.5 Tekmira Recent Development
10.16 Alnylam Pharmaceuticals
10.16.1 Alnylam Pharmaceuticals Company Information
10.16.2 Alnylam Pharmaceuticals Introduction and Business Overview
10.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Alnylam Pharmaceuticals RNA Drugs Products Offered
10.16.5 Alnylam Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 RNA Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 RNA Drugs Industrial Chain Analysis
11.4 RNA Drugs Market Dynamics
11.4.1 RNA Drugs Industry Trends
11.4.2 RNA Drugs Market Drivers
11.4.3 RNA Drugs Market Challenges
11.4.4 RNA Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 RNA Drugs Distributors
12.3 RNA Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of siRNA
Table 2. Major Company of ASO
Table 3. Major Company of miRNA
Table 4. Major Company of Nucleic Acid Aptamers
Table 5. Global RNA Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global RNA Drugs Sales by Type (2018-2024) & (K Units)
Table 7. Global RNA Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global RNA Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global RNA Drugs Market Share in Value by Type (2018-2024)
Table 10. Global RNA Drugs Price by Type (2018-2024) & (USD/Unit)
Table 11. Global RNA Drugs Sales by Type (2024-2034) & (K Units)
Table 12. Global RNA Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global RNA Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global RNA Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global RNA Drugs Price by Type (2024-2034) & (USD/Unit)
Table 16. North America RNA Drugs Sales by Type (2018-2024) & (K Units)
Table 17. North America RNA Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe RNA Drugs Sales (K Units) by Type (2018-2024)
Table 19. Europe RNA Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific RNA Drugs Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific RNA Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America RNA Drugs Sales (K Units) by Type (2018-2024)
Table 23. Latin America RNA Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa RNA Drugs Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa RNA Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global RNA Drugs Sales by Company (2018-2024) & (K Units)
Table 27. Global RNA Drugs Sales Share by Company (2018-2024)
Table 28. Global RNA Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global RNA Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market RNA Drugs Price by Company (2018-2024) & (USD/Unit)
Table 31. Global RNA Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into RNA Drugs Market
Table 35. Key Manufacturers RNA Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global RNA Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global RNA Drugs Sales by Region (2018-2024) & (K Units)
Table 39. Global RNA Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global RNA Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global RNA Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global RNA Drugs Sales by Region (2024-2034) & (K Units)
Table 44. Global RNA Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global RNA Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global RNA Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global RNA Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global RNA Drugs Sales by Application (2018-2024) & (K Units)
Table 50. Global RNA Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global RNA Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global RNA Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global RNA Drugs Price by Application (2018-2024) & (USD/Unit)
Table 54. Global RNA Drugs Sales by Application (2024-2034) & (K Units)
Table 55. Global RNA Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global RNA Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global RNA Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global RNA Drugs Price by Application (2024-2034) & (USD/Unit)
Table 59. North America RNA Drugs Sales by Application (2018-2024) (K Units)
Table 60. North America RNA Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe RNA Drugs Sales by Application (2018-2024) (K Units)
Table 62. Europe RNA Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific RNA Drugs Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific RNA Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America RNA Drugs Sales by Application (2018-2024) (K Units)
Table 66. Latin America RNA Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa RNA Drugs Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa RNA Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America RNA Drugs Sales by Country (2018-2024) & (K Units)
Table 70. North America RNA Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America RNA Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America RNA Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 74. North America RNA Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America RNA Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America RNA Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe RNA Drugs Sales by Country (2018-2024) & (K Units)
Table 78. Europe RNA Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe RNA Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe RNA Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 82. Europe RNA Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe RNA Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe RNA Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific RNA Drugs Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific RNA Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific RNA Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific RNA Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific RNA Drugs Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific RNA Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific RNA Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific RNA Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America RNA Drugs Sales by Country (2018-2024) & (K Units)
Table 94. Latin America RNA Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America RNA Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America RNA Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 98. Latin America RNA Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America RNA Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America RNA Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa RNA Drugs Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa RNA Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa RNA Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa RNA Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa RNA Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa RNA Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa RNA Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer RNA Drugs Product
Table 113. Pfizer Recent Development
Table 114. Roche Company Information
Table 115. Roche Introduction and Business Overview
Table 116. Roche RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Roche RNA Drugs Product
Table 118. Roche Recent Development
Table 119. Sanofi-Aventis Company Information
Table 120. Sanofi-Aventis Introduction and Business Overview
Table 121. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Sanofi-Aventis RNA Drugs Product
Table 123. Sanofi-Aventis Recent Development
Table 124. Abbott Laboratories Company Information
Table 125. Abbott Laboratories Introduction and Business Overview
Table 126. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Abbott Laboratories RNA Drugs Product
Table 128. Abbott Laboratories Recent Development
Table 129. Arrowhead Pharmaceuticals Company Information
Table 130. Arrowhead Pharmaceuticals Introduction and Business Overview
Table 131. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Arrowhead Pharmaceuticals RNA Drugs Product
Table 133. Arrowhead Pharmaceuticals Recent Development
Table 134. Benitec Biopharma Company Information
Table 135. Benitec Biopharma Introduction and Business Overview
Table 136. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Benitec Biopharma RNA Drugs Product
Table 138. Benitec Biopharma Recent Development
Table 139. Calimmune Inc Company Information
Table 140. Calimmune Inc Introduction and Business Overview
Table 141. Calimmune Inc RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Calimmune Inc RNA Drugs Product
Table 143. Calimmune Inc Recent Development
Table 144. Dicerna Company Information
Table 145. Dicerna Introduction and Business Overview
Table 146. Dicerna RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Dicerna RNA Drugs Product
Table 148. Dicerna Recent Development
Table 149. Gradalis Company Information
Table 150. Gradalis Introduction and Business Overview
Table 151. Gradalis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Gradalis RNA Drugs Product
Table 153. Gradalis Recent Development
Table 154. Quark Company Information
Table 155. Quark Introduction and Business Overview
Table 156. Quark RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Quark RNA Drugs Product
Table 158. Quark Recent Development
Table 159. RXi Company Information
Table 160. RXi Introduction and Business Overview
Table 161. RXi RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. RXi RNA Drugs Product
Table 163. RXi Recent Development
Table 164. Senesco Company Information
Table 165. Senesco Introduction and Business Overview
Table 166. Senesco RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Senesco RNA Drugs Product
Table 168. Senesco Recent Development
Table 169. Silence Therapeutics Company Information
Table 170. Silence Therapeutics Introduction and Business Overview
Table 171. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Silence Therapeutics RNA Drugs Product
Table 173. Silence Therapeutics Recent Development
Table 174. Silenseed Company Information
Table 175. Silenseed Introduction and Business Overview
Table 176. Silenseed RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Silenseed RNA Drugs Product
Table 178. Silenseed Recent Development
Table 179. Tekmira Company Information
Table 180. Tekmira Introduction and Business Overview
Table 181. Tekmira RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Tekmira RNA Drugs Product
Table 183. Tekmira Recent Development
Table 184. Alnylam Pharmaceuticals Company Information
Table 185. Alnylam Pharmaceuticals Introduction and Business Overview
Table 186. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Alnylam Pharmaceuticals RNA Drugs Product
Table 188. Alnylam Pharmaceuticals Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. RNA Drugs Market Trends
Table 192. RNA Drugs Market Drivers
Table 193. RNA Drugs Market Challenges
Table 194. RNA Drugs Market Restraints
Table 195. RNA Drugs Distributors List
Table 196. RNA Drugs Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Drugs Product Picture
Figure 2. Global RNA Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global RNA Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global RNA Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of siRNA
Figure 6. Global siRNA Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of ASO
Figure 8. Global ASO Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of miRNA
Figure 10. Global miRNA Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Nucleic Acid Aptamers
Figure 12. Global Nucleic Acid Aptamers Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global RNA Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global RNA Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America RNA Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America RNA Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe RNA Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe RNA Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific RNA Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific RNA Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America RNA Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America RNA Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa RNA Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa RNA Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA Drugs Revenue in 2022
Figure 27. RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Cancer
Figure 29. Global Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Diabetes
Figure 31. Global Diabetes Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Tuberculosis
Figure 33. Global Tuberculosis Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Cardiovascular Diseases
Figure 35. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Global RNA Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global RNA Drugs Sales Market Share by Application in 2022 & 2034
Figure 40. North America RNA Drugs Sales Market Share in Volume by Application in 2022
Figure 41. North America RNA Drugs Sales Market Share in Value by Application in 2022
Figure 42. Europe RNA Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Europe RNA Drugs Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific RNA Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific RNA Drugs Sales Market Share in Value by Application in 2022
Figure 46. Latin America RNA Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Latin America RNA Drugs Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa RNA Drugs Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. RNA Drugs Manufacturing Cost Structure
Figure 51. RNA Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed